Shanghai INT Medical Instruments Co (HKSE:01501) ROCE % : 12.90% (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai INT Medical Instruments Co's annualized ROCE % for the quarter that ended in Jun. 2024 was 12.90%.

Shanghai INT Medical Instruments Co ROCE % Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co ROCE % Chart

Shanghai INT Medical Instruments Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

10.98

11.33

9.09

10.70

12.06

Shanghai INT Medical Instruments Co Semi-Annual Data
	Dec16	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROCE %	Get a 7-Day Free Trial										11.14	11.03	10.62	12.90	11.67

Shanghai INT Medical Instruments Co ROCE % Calculation

Shanghai INT Medical Instruments Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	195.045	/	( ( (2040.611 - 267.637)	+	(2219.962 - 346.541) )	/ 2 )
	=	195.045	/	( (1772.974	+	1873.421)	/ 2 )
	=	195.045	/	1823.1975
	=	10.70 %

Shanghai INT Medical Instruments Co's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	240.674	/	( ( (2219.962 - 346.541)	+	(2116.293 - 258.162) )	/ 2 )
	=	240.674	/	( ( 1873.421	+	1858.131 )	/ 2 )
	=	240.674	/	1865.776
	=	12.90 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Shanghai INT Medical Instruments Co (HKSE:01501) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shanghai INT Medical Instruments Co ROCE % Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai INT Medical Instruments Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803

Website

https://www.int-medical.com

Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention or implantation and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, The United States and Other countries and regions. The majority of revenue is from the Chinese Mainland.

Executives

China Orient Asset Management (international) Holding Limited	2201 Interest of corporation controlled by you
Zhao Wei	2202 Interest of your spouse
Wang Kai	2201 Interest of corporation controlled by you
Ningbo Huaige Taiyi Equity Investment Partnership (limited Partnership)	2101 Beneficial owner
Ningbo Huaige Health Investment Management Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Ningbo Huaige Gongxin Equity Investment Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Central Huijin Investment Ltd.	2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.	2106 Person having a security interest in shares
Orbimed Capital Llc	2102 Investment manager
Zhao Wei	2202 Interest of your spouse
Zheng Aiping	2501 Other
Zhang Xianmiao	2501 Other
Zhang Wei	2501 Other
Shanghai Kindly Holding Group Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Kindly Enterprise Development Group Co., Ltd.	2101 Beneficial owner

Shanghai INT Medical Instruments Co Headlines

No Headlines